Lv52
1110 积分 2021-09-09 加入
Circulating tumor DNA (ctDNA) by clonoSEQ to monitor residual disease after axicabtagene ciloleucel (axi-cel) in large B-cell lymphoma (LBCL)
3小时前
已关闭
MRD Status By Clonoseq ® Is a Poor Predictor of Long-Term Outcomes after Bispecific LV20.19 CAR T-Cell Therapy for Relapsed, Refractory B-Cell NHL
3小时前
求助中
Molecular Disease Monitoring in Patients With Relapsed/refractory B-Cell Lymphoma Receiving Anti-CD19 CAR T-Cell Therapy
3小时前
已完结
ClonoSEQ assay for the detection of lymphoid malignancies
4小时前
已完结
Risk factors and outcomes of asparaginase-associated pancreatitis in pediatric patients with ALL
23小时前
已关闭
Core binding factor and its role in normal hematopoietic development
1个月前
已关闭
The UK ALLR3 Chemotherapy Regimen for Relapsed/Refractory Acute Lymphoblastic Leukemia of Childhood: A Multi-Institutional Retrospective Study of Treatment Related Adverse Events
1个月前
已关闭
Acute lymphocytic leukaemia
1个月前
已完结
皖公网安备34019202002308
